GeneNews (GEN) Reaches New 12-Month Low at $0.04

GeneNews Ltd (TSE:GEN) hit a new 52-week low during trading on Monday . The stock traded as low as C$0.04 and last traded at C$0.04, with a volume of 192700 shares. The stock had previously closed at C$0.04.

TRADEMARK VIOLATION NOTICE: “GeneNews (GEN) Reaches New 12-Month Low at $0.04” was reported by Transcript Daily and is the property of of Transcript Daily. If you are reading this report on another website, it was copied illegally and reposted in violation of US and international copyright legislation. The correct version of this report can be accessed at

GeneNews Company Profile (TSE:GEN)

GeneNews Limited focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology, the Sentinel Principle, identifies novel biomarkers from whole blood.

See Also: Cost of Debt

Receive News & Ratings for GeneNews Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeneNews and related companies with's FREE daily email newsletter.

Leave a Reply